Could this diabetes drug be a game changer for weight loss?
Semaglutide, a
Novo Nordisk drug that s currently approved to treat Type 2 diabetes, appeared to help obese patients lose an average of 15% of their body weight when paired with dietary and lifestyle changes, according to trial results published in the
New England Journal of Medicine (NEJM) but some experts say the trial contained notable limitations.
For the trial, researchers at
Northwestern University enrolled 1,961 adults who had a body mass index (BMI) of at least 30, or a BMI of at least 27 with at least one coexisting condition related to their weight that was not Type 2 diabetes. The trial took place at 129 centers across 16 countries, and it involved participants self-injecting either semaglutide or a placebo once each week for 68 weeks. The trial was blinded, so participants do not know whether they were self-administering semaglutide or a placebo. During the study period, participants also received indi
One-third of study participants treated with semaglutide lost at least 20% (46 pounds) of their baseline weight, which is a common reduction for many patients who have had bariatric surgery in the 1 to 3 years following their procedure.<br />
To analyze the outcomes of drinking caffeinated coffee, researchers categorized consumption as 0 cups per day, 1 cup per day, 2 cups per day, and more than or equal to 3 cups per day.
On a day in which the attention of some will focus on figurative heart symbols as a means of expressing love and affection, I wish to take a moment to reflect upon the actions of a Black surgeon who literally changed the approach to treating the human heart. And used the spirit of perseverance to eliminate a series of injustices.
In Chicago, Illinois, at Provident Hospital in 1893, Dr. Daniel Hale Williams performed open heart surgery on a patient who had suffered multiple chest stab wounds. The innovative actions saved the patient s life and forever changed the medical community s landscape and approach to treating a damaged heart.
Share this article
Share this article
CHICAGO, Feb. 13, 2021 /PRNewswire/ The American College of Prosthodontists (ACP) welcomes Mark C. Hutten, DDS, MS, FACP, as the organization s new president. Dr. Hutten was sworn in during a virtual ceremony at the 50
th anniversary Annual Session of the ACP, Nov. 1 to 7, 2020. As the ACP just celebrated a historic 50 years, I am looking forward to leading the College into our next chapter, said Dr. Hutten. I hope all of us in the specialty can collaborate together to ensure the strength and success of prosthodontics well into the future.
The American College of Prosthodontists (ACP) welcomes Mark C. Hutten, DDS, MS, FACP, as the organization’s new president. Dr. Hutten was sworn in during a virtual ceremony at the 50th anniversary Annual Session of the ACP, Nov. 1 to 7, 2020.